human | Q5 |
P735 | given name | Lars | Q15635262 |
Lars | Q15635262 | ||
P106 | occupation | researcher | Q1650915 |
Q43197715 | A human full-skin culture system for interventional studies. |
Q40746569 | A novel human skin chamber model to study wound infection ex vivo |
Q45862111 | A novel titanium wound chamber for the study of wound infections in pigs. |
Q53809169 | A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice. |
Q51737373 | Accelerated angiogenic induction and vascular integration in a novel synthetic scaffolding matrix for tissue replacement. |
Q34108244 | Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns |
Q36761588 | Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases |
Q39866579 | Antiseptics in surgery |
Q41941685 | Biphasic synovial sarcoma of the extremity: quadruple approach of isolated limb perfusion, surgical ablation, adipofascial perforator flap and radiation to avoid amputation |
Q51654253 | Bronchoscopy screening in primary oral squamous cell carcinoma: a 10-year experience. |
Q24814363 | Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats |
Q34984001 | Burn-induced organ dysfunction: vagus nerve stimulation attenuates organ and serum cytokine levels |
Q41334331 | Burn-induced organ dysfunction: vagus nerve stimulation improves cardiac function |
Q33249097 | Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues |
Q47666969 | Cryopreserved human amniotic membrane for soft tissue repair in rats |
Q37756018 | Diagnosis and management of primary breast sarcoma |
Q39867194 | Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity |
Q35633737 | Elastofibroma dorsi--differential diagnosis in chest wall tumours |
Q37256217 | Electrotransfer parameters as a tool for controlled and targeted gene expression in skin |
Q33321948 | Enhanced susceptibility to infections in a diabetic wound healing model |
Q33289550 | Epiploic appendagitis--clinical characteristics of an uncommon surgical diagnosis |
Q57184714 | Establishing efficient xenograft models with intrinsic vascularisation for growing primary human low-grade sarcomas |
Q39562979 | Establishment of a synovial sarcoma model in athymic nude mice |
Q33804879 | Evaluation of human amniotic membrane as a wound dressing for split-thickness skin-graft donor sites. |
Q33799990 | Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery. |
Q39804558 | Evaluation of toxic side effects of clinically used skin antiseptics in vitro. |
Q40191396 | Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma |
Q53158425 | Experimental murine model of primary high grade undifferentiated pleomorphic sarcoma not otherwise specified. |
Q51819406 | Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. |
Q24796008 | Feasibility of chemosensitivity testing in soft tissue sarcomas |
Q80993795 | Fournier's gangrene after Milligan-Morgan hemorrhoidectomy requiring subsequent abdominoperineal resection of the rectum: report of a case |
Q39608984 | Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas |
Q39488599 | Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model |
Q39174805 | Growth rate of late passage sarcoma cells is independent of epigenetic events but dependent on the amount of chromosomal aberrations |
Q37108625 | Host defense peptides and the new line of defence against multiresistant infections |
Q37786712 | Host defense peptides and their antimicrobial-immunomodulatory duality |
Q35010044 | Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? |
Q37127271 | Host defense peptides in wound healing. |
Q34167884 | Induction of angiogenesis and neovascularization in adjacent tissue of plasma-collagen-coated silicone implants |
Q24803217 | Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides |
Q34373912 | Innate defense regulator peptide 1018 in wound healing and wound infection |
Q41453719 | Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5. |
Q64931252 | Intravital monitoring of microcirculatory and angiogenic response to lactocapromer terpolymer matrix in a wound model. |
Q33532226 | Laser-mediated fixation of collagen-based scaffolds to dermal wounds. |
Q30157383 | Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study. |
Q55451307 | Malignant fibrous histiocytoma—pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study. |
Q33818284 | Microsurgical reconstruction of the oral cavity with free flaps from the anterolateral thigh and the radial forearm: a comparison of perioperative data from 161 cases. |
Q40135060 | Nucleofection: a new method for cutaneous gene transfer? |
Q38928882 | Numerical and structural chromosomal anomalies in undifferentiated pleomorphic sarcoma |
Q35600198 | Oncolytic activities of host defense peptides |
Q33670905 | Oncolytic designer host defense peptide suppresses growth of human liposarcoma |
Q41813290 | Papillon-Lefèvre syndrome and squamous cell carcinoma: a case report |
Q53088990 | Pressure garment therapy alone and in combination with silicone for the prevention of hypertrophic scarring: randomized controlled trial with intraindividual comparison. |
Q37110014 | Proximal major limb amputations--a retrospective analysis of 45 oncological cases |
Q44457507 | Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features |
Q40120614 | Repair of oronasal fistulae by interposition of multilayered amniotic membrane allograft. |
Q47706495 | Repair of oronasal fistulas with human amniotic membrane in minipigs |
Q24810525 | Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways |
Q45926277 | Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma--value of endoscopic screening: 10-year experience. |
Q37037135 | Role of host defense peptides of the innate immune response in sepsis |
Q37696015 | Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing |
Q33869797 | Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide |
Q39905680 | TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. |
Q45352256 | The Vascularised Groin Chamber: A Novel Model for Growing Primary Human Liposarcoma in Nude Mice |
Q45003781 | The effectiveness of pedicled groin flaps in the treatment of hand defects: results of 49 patients |
Q33375369 | The role of allogenic amniotic membrane in burn treatment |
Search more.